NATROX® O₂ for Complex Surgical/Radiation Wounds
Hard-to-heal surgical wounds and late radiation tissue injury
Evidence GenerationActive
Key Facts
Indication
Hard-to-heal surgical wounds and late radiation tissue injury
Phase
Evidence Generation
Status
Active
Company
About Inotec AMD
Inotec AMD is a commercial-stage medical device company addressing the significant global burden of chronic wounds through its innovative NATROX® O₂ topical oxygen delivery system. The device has garnered strong clinical support, including high-level guideline recommendations from international bodies like the IWGDF and ADA for diabetic foot ulcers. With a growing evidence base, key distributor partnerships, and availability through major channels like the NHS Supply Chain, the company is positioned to capture share in the large and costly chronic wound care market.
View full company profile